For almost a decade, companies have partnered with the Microbiome Movement Drug Development Summit, as a proven way to elevate their brand and expertise to attract the attention of key decision-makers.

Returning to unite biopharma’s C-Level and technical leaders, they’re actively attending a program designed to help all tap into game-changing technologies creating new possibilities for novel R&D, and address bottlenecks in the clinical and manufacture arenas.

As industry’s premier platform for connection building in 2024 and a prioritized yearly touchpoint uniting leading biopharma stakeholders, the 9th Microbiome Movement Drug Development Summit is your unmissable opportunity to showcase your capabilities to companies urgently looking to close the translational gap and gain pipeline efficiencies through establishing new partnerships.